Clinical trial

NAD-supplementation in Drug naïve Parkinson's Disease

NCT03816020

Study summary

ClinicalTrials.gov

NAD-supplementation in Drug naïve Parkinson's Disease

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DIETARY_SUPPLEMENT · Unmapped registry intervention Nicotinamide Riboside Find medicine records · Find other trials using this name

OTHER · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-03-09

PhaseNA

Conditions

Parkinson Diseaseverified · MONDO: Parkinson disease

Neurodegenerative Diseasesunresolved

Interventions

Nicotinamide RibosideDIETARY_SUPPLEMENT

PlaceboOTHER

Sponsors & collaborators

Haukeland University Hospitallead sponsor

Mapped research locations

BergenHordaland, Norway1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03816020 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.